TREGABLE Trademark

Trademark Overview


On Friday, September 11, 2020, a trademark application was filed for TREGABLE with the United States Patent and Trademark Office. The USPTO has given the TREGABLE trademark a serial number of 90175255. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2023. This trademark is owned by TeraImmune, Inc.. The TREGABLE trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals

Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies...

Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells;scientific and med...
tregable

General Information


Serial Number90175255
Word MarkTREGABLE
Filing DateFriday, September 11, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements


Goods and ServicesCustom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals
Goods and ServicesProviding medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy
Goods and ServicesMedical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells;scientific and medical research consultancy relating to all the aforesaid services

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBOUNCE MERGER SUB II, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMALVERN, PA 19355

Party NameTeraImmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Party NameTeraImmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events


Event DateEvent Description
Tuesday, September 15, 2020NEW APPLICATION ENTERED
Tuesday, October 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 21, 2021ASSIGNED TO EXAMINER
Friday, January 29, 2021NON-FINAL ACTION WRITTEN
Friday, January 29, 2021NON-FINAL ACTION E-MAILED
Friday, January 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, April 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, July 2, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 20, 2021ASSIGNED TO PETITION STAFF
Tuesday, July 20, 2021CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Sunday, October 3, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 18, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 18, 2022SOU EXTENSION 1 FILED
Monday, April 18, 2022SOU EXTENSION 1 GRANTED
Wednesday, April 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 16, 2022SOU EXTENSION 2 FILED
Wednesday, November 16, 2022SOU EXTENSION 2 GRANTED
Friday, November 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 9, 2023SOU EXTENSION 3 FILED
Tuesday, May 9, 2023SOU EXTENSION 3 GRANTED
Thursday, May 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 26, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 5, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED